Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Transfusional Iron Overload”

51 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 51 results

Large-scale testing (Phase 3)Study completedNCT00061750
What this trial is testing

Safety & Efficacy of ICL670 vs. Deferoxamine in Beta-thalassemia Patients With Iron Overload Due to Blood Transfusions

Who this might be right for
Beta-Thalassemia
Novartis Pharmaceuticals 595
Not applicableLooking for participantsNCT04171635
What this trial is testing

Quantitative Susceptibility Mapping (QSM) to Guide Iron Chelating Therapy

Who this might be right for
MRI Scans
Weill Medical College of Cornell University 42
Testing effectiveness (Phase 2)Study completedNCT00631163
What this trial is testing

Efficacy and Safety of Deferasirox in Patients With Chronic Anemia and Transfusional Hemosiderosis

Who this might be right for
Chronic AnemiaTransfusional Hemosiderosis
Novartis Pharmaceuticals 102
Testing effectiveness (Phase 2)Study completedNCT00069862
What this trial is testing

Iron Balance Study of DFO and GT56-252 in Patients With Transfusional Iron Overload Secondary to Beta-Thalassemia

Who this might be right for
Beta-Thalassemia
Genzyme, a Sanofi Company 25
Testing effectiveness (Phase 2)Study completedNCT00395629
What this trial is testing

Safety and Efficacy of Deferasirox (ICL670) in Patients With Iron Overload Resulting From Hereditary Hemochromatosis

Who this might be right for
Iron OverloadHereditary Hemochromatosis
Novartis Pharmaceuticals 49
Large-scale testing (Phase 3)Study completedNCT00469560
What this trial is testing

Safety, Tolerability, and Efficacy of Deferasirox in MDS

Who this might be right for
Myelodysplastic SyndromesHemosiderosis
Gruppo Italiano Malattie EMatologiche dell'Adulto 158
Testing effectiveness (Phase 2)Ended earlyNCT01363908
What this trial is testing

Safety, Efficacy and Pharmacokinetics of an Oral Iron Chelator Given for a Year to Pediatric Patients With Iron Overload

Who this might be right for
Transfusional Iron OverloadBeta-Thalassemia
Shire 30
Testing effectiveness (Phase 2)Study completedNCT00379483
What this trial is testing

Extension Study of Iron Chelation Therapy With Deferasirox in Patients With Transfusional Iron Overload

Who this might be right for
Transfusional Iron Overload
Novartis Pharmaceuticals 66
Testing effectiveness (Phase 2)Study completedNCT00061763
What this trial is testing

Study of Deferasirox in Iron Overload From Beta-thalassemia Unable to be Treated With Deferoxamine or Chronic Anemias

Who this might be right for
Beta-thalassemiaMyelodysplastic SyndromesFanconi Syndrome+2 more
Novartis Pharmaceuticals 175
Not applicableStudy completedNCT00001203
What this trial is testing

Deferoxamine for the Treatment of Hemochromatosis

Who this might be right for
Diabetes MellitusHeart DiseaseHemochromatosis+1 more
National Heart, Lung, and Blood Institute (NHLBI) 151
Not applicableStudy completedNCT01838291
What this trial is testing

Active Drug Surveillance Program of Ferriprox Use

Who this might be right for
Transfusional Iron Overload
ApoPharma 294
Testing effectiveness (Phase 2)Study completedNCT00303329
What this trial is testing

Extension Study of Iron Chelation Therapy With Deferasirox in β-thalassemia and Rare Chronic Anemia Patients

Who this might be right for
AnemiaHemosiderosis
Novartis Pharmaceuticals 184
Testing effectiveness (Phase 2)Study completedNCT01709032
What this trial is testing

Combination Deferasirox and Deferiprone for Severe Iron Overload in Thalassemia

Who this might be right for
Thalassemia Major With Severe Transfusional Iron Overload
Children's Hospital of Philadelphia 9
Post-approval studies (Phase 4)Study completedNCT00673608
What this trial is testing

Magnetic Resonance Imaging (MRI) Assessments of the Heart and Liver Iron Load in Patients With Transfusion Induced Iron Overload

Who this might be right for
HemoglobinopathiesMyelodysplastic SyndromesOther Inherited or Acquired Anaemia+4 more
Novartis 118
Testing effectiveness (Phase 2)Ended earlyNCT00602446
What this trial is testing

Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell Transplant

Who this might be right for
Breast CancerIron OverloadLeukemia+5 more
Masonic Cancer Center, University of Minnesota 4
Testing effectiveness (Phase 2)Study completedNCT00067080
What this trial is testing

Safety of ICL670 vs. Deferoxamine in Sickle Cell Disease Patients With Iron Overload Due to Blood Transfusions

Who this might be right for
Anemia, Sickle Cell
Novartis Pharmaceuticals 195
Post-approval studies (Phase 4)Study completedNCT00481143
What this trial is testing

Efficacy and Safety of Deferasirox in Patients With Myelodysplastic Syndrome and Transfusion-dependent Iron Overload

Who this might be right for
Myelodysplastic SyndromesTransfusion Dependent Iron Overload
Novartis Pharmaceuticals 63
Testing effectiveness (Phase 2)Study completedNCT02125877
What this trial is testing

Phase II Study to Investigate the Benefits of an Improved Deferasirox Formulation (Film-coated Tablet)

Who this might be right for
Chronic Iron Overload Due to Transfusion-dependant Anemias
Novartis Pharmaceuticals 173
Large-scale testing (Phase 3)Study completedNCT00171210
What this trial is testing

An Extension Study of Iron Chelation Therapy With Deferasirox (ICL670) in β-thalassemia Patients With Transfusional Iron Overload

Who this might be right for
Transfusional Iron Overload in β-thalassemia
Novartis Pharmaceuticals 506
Not applicableStudy completedNCT01241357
What this trial is testing

High-Tc Susceptometer to Monitor Transfusional Iron Overload

Who this might be right for
Transfusional Iron OverloadThalassemia MajorSickle Cell Disease+2 more
Columbia University 99
Load More Results